Austin Gillen
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polyadenylation | 4 | 2022 | 40 | 1.600 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2019 | 316 | 1.450 |
Why?
| Single-Cell Analysis | 7 | 2025 | 274 | 0.990 |
Why?
| Hibernation | 2 | 2023 | 74 | 0.910 |
Why?
| Torpor | 2 | 2023 | 14 | 0.850 |
Why?
| Neoplastic Cells, Circulating | 2 | 2020 | 70 | 0.820 |
Why?
| Transcriptome | 5 | 2024 | 875 | 0.770 |
Why?
| Leukemia, Myeloid, Acute | 6 | 2024 | 596 | 0.700 |
Why?
| Sequence Analysis, RNA | 8 | 2025 | 426 | 0.660 |
Why?
| Gene Expression Regulation | 6 | 2023 | 2545 | 0.630 |
Why?
| Bridged Bicyclo Compounds, Heterocyclic | 6 | 2025 | 217 | 0.610 |
Why?
| Ependymoma | 1 | 2020 | 161 | 0.590 |
Why?
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 486 | 0.590 |
Why?
| Chromosomes, Artificial, Bacterial | 2 | 2019 | 17 | 0.590 |
Why?
| Breast Neoplasms | 7 | 2020 | 2104 | 0.560 |
Why?
| Transgenes | 2 | 2019 | 178 | 0.540 |
Why?
| Sulfonamides | 6 | 2025 | 497 | 0.530 |
Why?
| Immunoprecipitation | 2 | 2016 | 156 | 0.530 |
Why?
| Gene Regulatory Networks | 2 | 2018 | 280 | 0.510 |
Why?
| Neoplastic Stem Cells | 4 | 2025 | 378 | 0.500 |
Why?
| Carcinogenesis | 1 | 2017 | 214 | 0.490 |
Why?
| Artifacts | 1 | 2016 | 126 | 0.490 |
Why?
| 3' Untranslated Regions | 5 | 2022 | 138 | 0.480 |
Why?
| Respiratory Mucosa | 1 | 2018 | 310 | 0.480 |
Why?
| RNA-Binding Proteins | 3 | 2023 | 388 | 0.480 |
Why?
| Mitochondrial Proteins | 1 | 2017 | 247 | 0.470 |
Why?
| Binding Sites | 2 | 2016 | 1251 | 0.420 |
Why?
| MicroRNAs | 4 | 2016 | 680 | 0.400 |
Why?
| Receptors, Estrogen | 5 | 2020 | 422 | 0.400 |
Why?
| Gene Transfer Techniques | 1 | 2013 | 164 | 0.380 |
Why?
| RNA | 2 | 2023 | 876 | 0.360 |
Why?
| Repressor Proteins | 2 | 2011 | 404 | 0.350 |
Why?
| Regulatory Sequences, Nucleic Acid | 3 | 2019 | 88 | 0.350 |
Why?
| Cystic Fibrosis | 2 | 2018 | 1066 | 0.340 |
Why?
| Cell Differentiation | 4 | 2021 | 1900 | 0.320 |
Why?
| Mammals | 2 | 2023 | 274 | 0.310 |
Why?
| Homeodomain Proteins | 4 | 2021 | 493 | 0.290 |
Why?
| Interferon-gamma | 1 | 2011 | 773 | 0.290 |
Why?
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 1327 | 0.290 |
Why?
| Non-alcoholic Fatty Liver Disease | 2 | 2020 | 260 | 0.260 |
Why?
| Animals | 21 | 2025 | 35404 | 0.260 |
Why?
| Transcription, Genetic | 2 | 2012 | 1416 | 0.260 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2025 | 1560 | 0.250 |
Why?
| Humans | 39 | 2025 | 129687 | 0.240 |
Why?
| Mitochondria | 2 | 2024 | 875 | 0.240 |
Why?
| Immunoglobulin Light Chains | 1 | 2025 | 40 | 0.230 |
Why?
| Osteolysis | 1 | 2025 | 18 | 0.230 |
Why?
| Gene Expression | 2 | 2023 | 1465 | 0.230 |
Why?
| Mice | 16 | 2025 | 16982 | 0.230 |
Why?
| Drug Resistance, Neoplasm | 4 | 2025 | 752 | 0.220 |
Why?
| Signal Transduction | 6 | 2020 | 4935 | 0.220 |
Why?
| Sciuridae | 2 | 2023 | 146 | 0.220 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2025 | 118 | 0.220 |
Why?
| Liver | 3 | 2024 | 1839 | 0.210 |
Why?
| MCF-7 Cells | 3 | 2020 | 114 | 0.210 |
Why?
| RNA, Messenger | 5 | 2021 | 2702 | 0.210 |
Why?
| Hematopoietic Stem Cells | 2 | 2024 | 382 | 0.210 |
Why?
| Nonsense Mediated mRNA Decay | 1 | 2023 | 12 | 0.210 |
Why?
| Multiple Myeloma | 1 | 2025 | 125 | 0.210 |
Why?
| Lipoproteins, LDL | 2 | 2020 | 127 | 0.200 |
Why?
| Protein Isoforms | 2 | 2022 | 393 | 0.200 |
Why?
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2023 | 26 | 0.200 |
Why?
| Antineoplastic Agents, Hormonal | 2 | 2021 | 155 | 0.200 |
Why?
| Lymphatic Vessels | 2 | 2020 | 61 | 0.200 |
Why?
| Estrogens | 4 | 2018 | 348 | 0.200 |
Why?
| Liver Cirrhosis | 1 | 2024 | 281 | 0.190 |
Why?
| Fatty Liver | 1 | 2024 | 230 | 0.190 |
Why?
| Azacitidine | 2 | 2022 | 137 | 0.180 |
Why?
| Mammary Neoplasms, Experimental | 1 | 2021 | 65 | 0.180 |
Why?
| Drosophila | 1 | 2022 | 141 | 0.180 |
Why?
| Weight Gain | 2 | 2021 | 510 | 0.170 |
Why?
| Leukocytes, Mononuclear | 2 | 2020 | 546 | 0.170 |
Why?
| Cells, Cultured | 6 | 2019 | 4102 | 0.170 |
Why?
| RNA, Small Cytoplasmic | 1 | 2020 | 7 | 0.170 |
Why?
| Adipose Tissue | 2 | 2021 | 594 | 0.170 |
Why?
| Neural Crest | 1 | 2021 | 115 | 0.170 |
Why?
| rac GTP-Binding Proteins | 1 | 2020 | 32 | 0.170 |
Why?
| Mouse Embryonic Stem Cells | 1 | 2020 | 30 | 0.160 |
Why?
| Gene Library | 2 | 2019 | 115 | 0.160 |
Why?
| DNA-Binding Proteins | 3 | 2020 | 1441 | 0.160 |
Why?
| Extracellular Fluid | 1 | 2019 | 31 | 0.160 |
Why?
| Gene Expression Profiling | 7 | 2024 | 1686 | 0.160 |
Why?
| rho GTP-Binding Proteins | 1 | 2020 | 60 | 0.160 |
Why?
| Decision Support Systems, Clinical | 1 | 2022 | 206 | 0.160 |
Why?
| Integrins | 1 | 2020 | 94 | 0.160 |
Why?
| Hedgehog Proteins | 1 | 2020 | 188 | 0.160 |
Why?
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 70 | 0.160 |
Why?
| Receptors, Progesterone | 2 | 2020 | 341 | 0.160 |
Why?
| Promoter Regions, Genetic | 3 | 2013 | 1213 | 0.150 |
Why?
| Protein Kinase Inhibitors | 1 | 2025 | 886 | 0.150 |
Why?
| Neural Stem Cells | 1 | 2020 | 142 | 0.150 |
Why?
| Hematopoiesis | 1 | 2020 | 184 | 0.150 |
Why?
| RNA Editing | 1 | 2018 | 20 | 0.150 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2020 | 201 | 0.150 |
Why?
| Oligodendroglia | 1 | 2020 | 167 | 0.150 |
Why?
| Calcium | 1 | 2024 | 1212 | 0.150 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2024 | 855 | 0.150 |
Why?
| Software | 2 | 2020 | 606 | 0.150 |
Why?
| Zebrafish Proteins | 1 | 2021 | 268 | 0.150 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 51 | 0.150 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 124 | 0.150 |
Why?
| Alveolar Epithelial Cells | 1 | 2019 | 107 | 0.150 |
Why?
| Motor Neurons | 1 | 2020 | 233 | 0.150 |
Why?
| Bleomycin | 1 | 2019 | 243 | 0.140 |
Why?
| RNA Polymerase III | 1 | 2017 | 26 | 0.140 |
Why?
| Neoplasm Metastasis | 1 | 2020 | 610 | 0.140 |
Why?
| Regeneration | 1 | 2019 | 182 | 0.140 |
Why?
| Superoxide Dismutase | 1 | 2019 | 342 | 0.140 |
Why?
| Hepatitis C, Chronic | 1 | 2019 | 156 | 0.140 |
Why?
| Progestins | 1 | 2017 | 78 | 0.130 |
Why?
| Obesity | 2 | 2021 | 2885 | 0.130 |
Why?
| Zebrafish | 1 | 2021 | 460 | 0.130 |
Why?
| Cancer-Associated Fibroblasts | 1 | 2016 | 13 | 0.130 |
Why?
| Biomarkers, Tumor | 2 | 2020 | 1161 | 0.130 |
Why?
| Bronchi | 1 | 2018 | 249 | 0.130 |
Why?
| Transforming Growth Factor beta | 1 | 2019 | 462 | 0.130 |
Why?
| Epididymis | 2 | 2013 | 12 | 0.130 |
Why?
| Lung Injury | 1 | 2019 | 211 | 0.130 |
Why?
| Macrophages, Alveolar | 1 | 2019 | 389 | 0.130 |
Why?
| Trachea | 1 | 2018 | 226 | 0.130 |
Why?
| Epithelial Cells | 2 | 2013 | 1063 | 0.130 |
Why?
| Disease-Free Survival | 1 | 2017 | 646 | 0.120 |
Why?
| Apoptosis | 3 | 2019 | 2489 | 0.120 |
Why?
| Ribosomal Proteins | 1 | 2015 | 77 | 0.120 |
Why?
| Extracellular Matrix | 1 | 2019 | 508 | 0.120 |
Why?
| Temperature | 1 | 2018 | 635 | 0.120 |
Why?
| DNA Primers | 1 | 2016 | 508 | 0.120 |
Why?
| Hypoxia | 1 | 2022 | 1085 | 0.120 |
Why?
| Sequence Analysis, DNA | 1 | 2018 | 778 | 0.120 |
Why?
| Reactive Oxygen Species | 1 | 2017 | 592 | 0.110 |
Why?
| CCCTC-Binding Factor | 2 | 2011 | 14 | 0.110 |
Why?
| Chromosome Mapping | 2 | 2013 | 499 | 0.110 |
Why?
| Neoplasms | 2 | 2021 | 2454 | 0.110 |
Why?
| Tamoxifen | 3 | 2021 | 197 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 953 | 0.110 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2021 | 820 | 0.110 |
Why?
| Endothelial Cells | 1 | 2019 | 749 | 0.110 |
Why?
| Spermatogenesis | 1 | 2013 | 62 | 0.110 |
Why?
| Mice, Inbred C57BL | 5 | 2024 | 5468 | 0.110 |
Why?
| Infertility, Male | 1 | 2013 | 61 | 0.110 |
Why?
| Nucleosomes | 2 | 2013 | 137 | 0.110 |
Why?
| Down-Regulation | 1 | 2015 | 631 | 0.100 |
Why?
| Enhancer Elements, Genetic | 2 | 2012 | 177 | 0.100 |
Why?
| Cluster Analysis | 3 | 2022 | 482 | 0.100 |
Why?
| Cell Line, Tumor | 4 | 2025 | 3184 | 0.100 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2013 | 99 | 0.100 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 216 | 0.100 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2013 | 307 | 0.100 |
Why?
| Genetic Vectors | 1 | 2013 | 312 | 0.090 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2015 | 503 | 0.090 |
Why?
| Genes, Regulator | 1 | 2011 | 35 | 0.090 |
Why?
| Caco-2 Cells | 1 | 2011 | 76 | 0.090 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1844 | 0.090 |
Why?
| Luciferases | 1 | 2011 | 147 | 0.090 |
Why?
| Oxidative Phosphorylation | 2 | 2024 | 188 | 0.090 |
Why?
| Mice, Transgenic | 3 | 2021 | 2135 | 0.090 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2011 | 88 | 0.090 |
Why?
| Hypertension, Pulmonary | 1 | 2022 | 1894 | 0.090 |
Why?
| Female | 12 | 2024 | 68751 | 0.090 |
Why?
| Tumor Microenvironment | 3 | 2020 | 627 | 0.080 |
Why?
| Protein Binding | 1 | 2016 | 2122 | 0.080 |
Why?
| Insulator Elements | 1 | 2009 | 2 | 0.080 |
Why?
| 3' Flanking Region | 1 | 2009 | 7 | 0.080 |
Why?
| Blotting, Western | 1 | 2011 | 1204 | 0.080 |
Why?
| Inflammation | 1 | 2019 | 2748 | 0.070 |
Why?
| CD146 Antigen | 2 | 2020 | 41 | 0.070 |
Why?
| Prognosis | 3 | 2025 | 3772 | 0.070 |
Why?
| Tumor Cells, Cultured | 2 | 2020 | 930 | 0.070 |
Why?
| Disease Models, Animal | 3 | 2024 | 4076 | 0.070 |
Why?
| Male | 10 | 2025 | 63691 | 0.060 |
Why?
| Brain | 1 | 2018 | 2677 | 0.060 |
Why?
| Chromatin | 1 | 2009 | 478 | 0.060 |
Why?
| Blast Crisis | 1 | 2025 | 33 | 0.060 |
Why?
| Disease Progression | 2 | 2023 | 2628 | 0.050 |
Why?
| Antigens, CD34 | 1 | 2023 | 88 | 0.050 |
Why?
| Serine-Arginine Splicing Factors | 1 | 2023 | 22 | 0.050 |
Why?
| Bone Marrow Cells | 1 | 2024 | 302 | 0.050 |
Why?
| Bone Marrow | 1 | 2024 | 272 | 0.050 |
Why?
| Mice, Obese | 1 | 2021 | 63 | 0.050 |
Why?
| Aromatase Inhibitors | 1 | 2021 | 51 | 0.050 |
Why?
| Thinness | 1 | 2021 | 89 | 0.040 |
Why?
| Intercellular Junctions | 1 | 2020 | 39 | 0.040 |
Why?
| Child | 1 | 2020 | 20882 | 0.040 |
Why?
| Organogenesis | 1 | 2021 | 56 | 0.040 |
Why?
| Proteostasis | 1 | 2020 | 27 | 0.040 |
Why?
| Permeability | 1 | 2020 | 158 | 0.040 |
Why?
| Embryoid Bodies | 1 | 2020 | 7 | 0.040 |
Why?
| Head | 1 | 2021 | 96 | 0.040 |
Why?
| Morphogenesis | 1 | 2021 | 158 | 0.040 |
Why?
| Skull | 1 | 2021 | 129 | 0.040 |
Why?
| Colony-Forming Units Assay | 1 | 2020 | 90 | 0.040 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2024 | 707 | 0.040 |
Why?
| Cartilage | 1 | 2021 | 183 | 0.040 |
Why?
| Diet, High-Fat | 1 | 2020 | 239 | 0.040 |
Why?
| Tricarboxylic Acids | 1 | 2018 | 10 | 0.040 |
Why?
| Transcription Factors | 2 | 2021 | 1645 | 0.040 |
Why?
| Exocytosis | 1 | 2019 | 88 | 0.040 |
Why?
| Ketoglutaric Acids | 1 | 2018 | 16 | 0.040 |
Why?
| Antibiotics, Antineoplastic | 1 | 2019 | 123 | 0.040 |
Why?
| Mesoderm | 1 | 2020 | 138 | 0.040 |
Why?
| Gene Editing | 1 | 2019 | 68 | 0.040 |
Why?
| Electron Transport Complex II | 1 | 2018 | 25 | 0.040 |
Why?
| Succinate Dehydrogenase | 1 | 2018 | 46 | 0.040 |
Why?
| DNA, Complementary | 1 | 2019 | 266 | 0.040 |
Why?
| Loss of Function Mutation | 1 | 2018 | 38 | 0.040 |
Why?
| Primary Cell Culture | 1 | 2019 | 164 | 0.040 |
Why?
| Cell Adhesion | 1 | 2020 | 454 | 0.040 |
Why?
| Neoplasm Invasiveness | 1 | 2020 | 483 | 0.040 |
Why?
| Tumor Suppressor Proteins | 1 | 2020 | 311 | 0.040 |
Why?
| Receptor, ErbB-2 | 1 | 2020 | 325 | 0.040 |
Why?
| Lung | 2 | 2022 | 3937 | 0.040 |
Why?
| Fatty Acids | 1 | 2020 | 427 | 0.030 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 232 | 0.030 |
Why?
| Machine Learning | 1 | 2022 | 441 | 0.030 |
Why?
| Aged, 80 and over | 2 | 2019 | 7064 | 0.030 |
Why?
| Amino Acids | 1 | 2020 | 487 | 0.030 |
Why?
| Fibrosis | 1 | 2019 | 526 | 0.030 |
Why?
| Mice, SCID | 1 | 2017 | 350 | 0.030 |
Why?
| ErbB Receptors | 1 | 2020 | 605 | 0.030 |
Why?
| Lymphatic Metastasis | 1 | 2017 | 320 | 0.030 |
Why?
| Stem Cells | 1 | 2020 | 578 | 0.030 |
Why?
| Aged | 3 | 2020 | 22101 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2017 | 587 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2019 | 872 | 0.030 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 63 | 0.030 |
Why?
| Fibroblasts | 1 | 2020 | 954 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 808 | 0.030 |
Why?
| Macrophages | 1 | 2022 | 1489 | 0.030 |
Why?
| Evolution, Molecular | 1 | 2018 | 462 | 0.030 |
Why?
| Receptors, Steroid | 1 | 2014 | 49 | 0.030 |
Why?
| Expert Systems | 1 | 2013 | 3 | 0.030 |
Why?
| DNA, Intergenic | 1 | 2013 | 25 | 0.030 |
Why?
| Antineoplastic Agents | 1 | 2024 | 2044 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2014 | 283 | 0.030 |
Why?
| Chronic Disease | 1 | 2019 | 1723 | 0.030 |
Why?
| Organ Specificity | 1 | 2013 | 295 | 0.030 |
Why?
| Energy Metabolism | 1 | 2018 | 875 | 0.030 |
Why?
| Mice, Knockout | 1 | 2019 | 2888 | 0.020 |
Why?
| RNA Interference | 1 | 2014 | 450 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2019 | 2062 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 756 | 0.020 |
Why?
| Conserved Sequence | 1 | 2011 | 227 | 0.020 |
Why?
| Diet | 1 | 2018 | 1212 | 0.020 |
Why?
| Rats | 1 | 2019 | 5485 | 0.020 |
Why?
| Cell Proliferation | 1 | 2017 | 2378 | 0.020 |
Why?
| Computational Biology | 1 | 2013 | 594 | 0.020 |
Why?
| DNA Footprinting | 1 | 2009 | 33 | 0.020 |
Why?
| Fetus | 1 | 2013 | 776 | 0.020 |
Why?
| Deoxyribonuclease I | 1 | 2009 | 38 | 0.020 |
Why?
| Biomarkers | 1 | 2020 | 3969 | 0.020 |
Why?
| Treatment Outcome | 1 | 2022 | 10221 | 0.020 |
Why?
| Base Sequence | 1 | 2011 | 2142 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2013 | 1326 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2014 | 2739 | 0.020 |
Why?
| Adult | 2 | 2019 | 35607 | 0.020 |
Why?
| Middle Aged | 1 | 2019 | 31165 | 0.010 |
Why?
|
|
Gillen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|